chrisvoncsefalvay/vaers-outcomes huggingface dataset:
swollen lymph nodes; This spontaneous case was reported by a patient and describes the occurrence of LYMPHADENOPATHY (swollen lymph nodes) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jun-2021, the patient experienced LYMPHADENOPATHY (swollen lymph nodes). At the time of the report, LYMPHADENOPATHY (swollen lymph nodes) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication use was provided by the reporter.  No treatment of events was reported.
Short term memory loss, blurred vision, bad memory no strength, dizziness, poor tolerance to bright light, ache joints, acid reflux, night sweats, rashes, photophobia, pain in muscle and joints, depression, loss of concentration and others.
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a female patient who received SHINGRIX for prophylaxis. In September 2018, the patient received the 1st dose of SHINGRIX. In September 2018, 3 hrs after receiving SHINGRIX, the patient experienced injection site pain and injection site discomfort. On an unknown date, the patient experienced injected limb mobility decreased and crying. The patient was treated with cortisone acetate. On an unknown date, the outcome of the injection site pain and injection site discomfort were recovered/resolved and the outcome of the injected limb mobility decreased and crying were unknown. It was unknown if the reporter considered the injection site pain, injection site discomfort, injected limb mobility decreased and crying to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient received the 1st shot in the middle of September 2018 on left arm, the exact date was unknown. She reported experiencing severe pain in her left arm. The pain presented 3 to 4 hours following the vaccination and lasted 9 to 10 days. She had a cortisone shot in the 4th day which helped with the pain. The pain was so bad that she couldn't lift her arm and she was in tears. She also described the feeling of a lump being injected at the time the vaccine was administered. She said it felt like a large amount of liquid was going in. Her husband felt the same thing. The reporter gave consent to follow up. This case has been linked with case US2019031696, reported by the same reporter.
Information has been received from a physician concerning a female patient in her 70's who on 23 Jan 2007 was vaccinated with a dose of Zostavax vaccine live. On 02 Feb 2007 the patient developed a rash on her face. Unspecified medical attention was sought. There was no product quality complaint involved. No other information was provided. No further information is available.
mild to moderate abd cramping w/o vomiting or diarrhea x 5 days;slept through noc;afeb;no local rxn noted;presented to ER 25AUG(6 PM;
15-20 minutes after administration, pt began to experience nausea/dizziness, dry heaving, and lightheadedness-- bp dropped and pt passed out
HX OF VASOVAGAL RESPONSE.  VS :  67, O2 SAT 100%, 68/112.  FELT DIZZIE UPON STANDING AND FELL.  APPEARED TO BE RAPID SEIZURE.  RESOLVED WITHING SECONDS
Client fell forward after stating "I'm dizzy." She was unconscious for less than 15 seconds. Client was caught by RN and laid down in the floor against a chair. Given water and an ice pack. Mother drove client home from clinic. She called client at 1040. Client stated she was not dizzy and was fine.
fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever) and CHILLS (chills) in a female patient of an unknown age who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis.     No Medical History information was reported.  On an unknown date, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever) and CHILLS (chills). At the time of the report, PYREXIA (fever) and CHILLS (chills) outcome was unknown.      For mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  The patient got Moderna last time and she had fever and chills the next day.   Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 14-Nov-2023: Live follow-up information received included updated reference section.
Person received flu vaccine and was paralyzed and bed-bound for 18 days and had to receive physical therapy and treatments to recover
12/08/2001 Left deltoid swollen and sore. Left ear and left side of neck swollen, painful and reddened. red, raised rash on left, neck and into hair, still apparent on 12/11/2001. No swelling on deltoid area or shoulder. Afebrile. Referred to physician.
Dizzy, ataxic gait (wobbly) normal hand control. Deep tendon reflex's upper extremity lower extremity 2+ & equal. Symptoms started 2/15/04 until 2/16/04-quick recovery, same day.
This is a spontaneous report from a contactable reporter who reported for her son. This 9-months-old, male patient was administered with PREVNAR 13 single dose on 26Sep2012. The relevant medical history included cold and running nose both since an unknown duration. The relevant concomitant medication was none. The reporter mentioned that on 28Sep2012 morning the patient experienced hives and swelling all over face for which it was elaborated that his mouth, ears and eyes were swelled up after receiving PREVNAR 13. The reporter further stated that swelling got worse throughout the day and by the evening he was rushed to the emergency room. The reporter also mentioned that since an unknown date the patient had a very hard lump on his thigh at the site of vaccine administration. The relevant laboratory tests were none. Therapeutic measure taken for the reported events hives and swelling all over face included prednisone at a dose of 3 ml daily, BENADRYL at a dose of 2ml every 6 hours and ibuprofen at a dose of 1.8 ml every 6 hours and an unspecified antihistamine at an unknown dose and frequency all since an unknown date. The patient recovered from hives and swelling all over face on an unknown date however the clinical outcome of the other reported event was unknown at the time of report. Follow-up (07NOV20120: Follow-up attempts completed. No further information expected.
Information has been received from a registered nurse concerning a 11-year-old female who was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). On 24-SEP-2007, the patient developed chickenpox. The patient's mother sought medical attention via phone call with the school nurse who contacted the health department. No diagnostic labs were performed. At the time of the report the patient's status was recovering. A product quality complaint was not involved. This is one of several reports received from the same source. Follow-up information indicated the patient was not vaccinated at the health department. Her "condition resolved" on an unspecified date. No further information is available.
approx 24 hrs p/vax began to exp flu-like sx of chills, fever to 102, body aches, h/a; local react-redness, pain, large amount swelling @ site
Encephalitis, started with numbness legs and arms, slurred speech, admitted to hospital recovered in 24 hours back to baseline in 36 hours
21 year old male with history of pharyngitis within week prior to smallpox vaccination - Day #10 noticed b/l lower bicep rash with pruritis - rash progressed to deltoid area and ear - mildly pruritic.
Chills , fever , Severe headache , dizziness and loss of taste buds .  Tongue felt weird  for 3 weeks  I had  Covid in January already .
This spontaneous report was received from a licensed practical nurse and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, medical history or concomitant medication provided. On 12-NOV-2018, the patient was vaccinated with an expired dose of VAQTA lot # N030286, expiry date 10-NOV-2018, intramuscularly for prophylaxis. No adverse effects were reported. This is one of two reports received from the same reporter. Sender's Comments: US-009507513-1811USA009194.
The client reported dizziness and shortness of breath. RN noted the client's eyes were closed. Vitals obtained at 3:56PM were as follows: BP 190/90, HR 84, O2 99%. The client denied swelling of the throat or tongue. At 3:59 PM the client took 2 puffs of her albuterol inhaler. The client stated, "now I can see." The client reported her shortness of breath had improved, and she was able to tolerate light. Vitals obtained at 4:02PM were as follows: BP 131/80, HR 70, O2 99%. The client opened her eyes and stated, "I'm okay." The client denied any persistent symptoms. The client declined water and stated she had someone else driving her home. Vitals obtained at 4:08 PM were as follows: BP 141/76, HR 66, O2 97%. The client stated she was tired, but denied any other current symptoms. Vitals obtained at 4:19 PM were as follows: BP 149/75, HR 75, O2 98%. The client denied any current symptoms. RN recommended the client follow up with her primary care physician regarding her blood pressure. RN educated client on possible adverse reactions and when to seek medical care. The client left the vaccination site ambulating with a steady gait unassisted.
Attending Physician: MD Date of Admission: 4/12/2023, Hospital Day: 4 Date of Discharge: 4/15/2023  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Metabolic encephalopathy [G93.41] Respiratory insufficiency [R06.89] Sepsis due to pneumonia [J18.9, A41.9] Community acquired pneumonia, unspecified laterality [J18.9] Sepsis, due to unspecified organism, unspecified whether acute organ dysfunction present [A41.9] COVID-19 [U07.1]   HOSPITAL COURSE: 73yo woman with a PMH chronic right knee pain, allergic rhinitis, GERD, COPD and HTN here with acute encephalopathy for unclear reason. It looked infectious in etiology and workup was broad including workup of her acute on chronic right knee/leg pain. MRI right knee and xray of ankle were negative for infection but did show medial and lateral meniscus tears. Urinalysis was obtained and looks suspicious for UTI. Urine culture came back with klebsiella sensitive to the antibiotics that she is on for pneumonia. CXR was suggestive of pneumonia.and sepsis secondary covid 19 PNA with superimposed bacterial pneumonia. She had persistent high fevers with altered mentation which quickly resolved with antibiotic administration. Blood cultures remained NGTD at time of dictation. She was given decadron and remdesivir for covid which she tolerated well. She did have acute respiratory failure but was able to be weaned off oxygen and did not qualify for oxygen prior to discharge. She was transitioned to ceftin to complete her course of antibiotics. She was discharged to home in stable and improved condition with referral to the transition to home program.
Tingling in Left Lower Extremity  x 2 days and now spread to R leg and both hands.
2 minutes after immunization patient became pale, cool, clammy and nauseous. No LOC Patient was placed in recovery position to rest. Approx 15 minutes later patient was able to drink water, sit up and ambulate with out assistance. Mother advised to take child to ER or call EMS should symptoms return. VAERS report completed.
Chills After the Second Shot; Fever After the Second Shot; Body Aches After the Second Shot; Lymph Node Swelling in Left Armpit and a little in left side of Neck; Neck swelling; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills After the Second Shot), PYREXIA (Fever After the Second Shot), PAIN (Body Aches After the Second Shot), LYMPHADENOPATHY (Lymph Node Swelling in Left Armpit and a little in left side of Neck) and SWELLING (Neck swelling) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination.     No Medical History information was reported.  On 01-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 02-Apr-2021, the patient experienced CHILLS (Chills After the Second Shot), PYREXIA (Fever After the Second Shot), PAIN (Body Aches After the Second Shot), LYMPHADENOPATHY (Lymph Node Swelling in Left Armpit and a little in left side of Neck) and SWELLING (Neck swelling).   On 05-Apr-2021, PYREXIA (Fever After the Second Shot) had resolved. On 09-Apr-2021, CHILLS (Chills After the Second Shot) had resolved.   At the time of the report, PAIN (Body Aches After the Second Shot), LYMPHADENOPATHY (Lymph Node Swelling in Left Armpit and a little in left side of Neck) and SWELLING (Neck swelling) outcome was unknown. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.   This case was linked to MOD-2021-076671 (Patient Link).
Fever (102 degrees F) started approximately 5 hrs post vaccine and redness swelling at site of injection. Painful to touch and worsening over next couple of days. Fever has come down. Entire arm aches.
I had my vaccination on 10/17/2022. On 03/07/2023 I woke up with a sore throat. I had a little bit of congestion and running a low grade fever. I took a COVID-19 test on 03/07/2023 I tested COVID-19 positive. I started to have a cough and headache on 03/08/2023. I was prescribed PAXLOVID. on 03/08/2023. I presently feel ok but have slowly recovered. I am still struggling with fatigue on 05/02/2023.
Had injection site reaction (redness swelling) and headache within 1 hour of vaccination. Next morning woke up with itching that started in ear and moved throughout day to different areas of body. Patient stated worsened everyday. Took diphenhydramine on 5/28/2016 pm and it didn't help. Went into urgent care 5/29/2016.
sore throat; headache; body aches; fever; chills; dizzy; bleeding gums; swollen gum; blisters in his mouth; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team.  A 16 year-old male patient received bnt162b2 (BNT162B2), administered in deltoid left, administration date 21Jul2021 (Lot number: FA7484) as dose 1, single and administration date 13Aug2021 (Lot number: FC3180) as dose 2, single for covid-19 immunisation. Relevant medical history included: "Epilepsy" (unspecified if ongoing), notes: Epilepsy as a child then grew out of it. The patient's concomitant medications were not reported. The following information was reported: OROPHARYNGEAL PAIN (non-serious), outcome "unknown", described as "sore throat"; HEADACHE (non-serious), outcome "unknown", described as "headache"; PAIN (non-serious), outcome "unknown", described as "body aches"; PYREXIA (non-serious), outcome "unknown", described as "fever"; CHILLS (non-serious), outcome "unknown", described as "chills"; DIZZINESS (non-serious), outcome "unknown", described as "dizzy"; GINGIVAL BLEEDING (non-serious) with onset 15Aug2021, outcome "not recovered", described as "bleeding gums"; GINGIVAL SWELLING (non-serious) with onset 15Aug2021, outcome "not recovered", described as "swollen gum"; ORAL MUCOSAL BLISTERING (non-serious) with onset 15Aug2021, outcome "not recovered", described as "blisters in his mouth". Therapeutic measures were taken as a result of gingival swelling.  Additional Information: They are trying to locate information on any adverse reactions for pediatric patients having swollen and/or bleedin gums and blisters in the mouth. Reporter did completed safety report on behalf of patient today. Reporter clarifies: "He's having all the other reactions as well- sore throat, headache, body aches, fever, chills, dizzy spells when he gets up sometimes in addition to the swollen, bleeding gums and blisters in his mouth. Stated to caller a search in my resources as well as the PI for the vaccine contains no information about swollen, bleeding gums and blisters in the mouth being reported as a side effect in either the 12-15 year old or 6 year old and older groups. Spoke from the PI: 6.2 Post Authorization Experience LAB-1457-11.0 Revised: 12 August 2021. Referred to HCP. Spoke from the attached FAQ: treatment advice/recommendations for adverse event. Swollen gums: Treatment oral  care mouth rinse. Vaccination Facility Type: Pharmacy. Epilepsy as a child then grew out of it. Reporter clarified this was the patient's medical history not the family.   No follow-up attempts are possible. No further information is expected.
Arm is sore at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Arm is sore at the injection site) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced INJECTION SITE PAIN (Arm is sore at the injection site). At the time of the report, INJECTION SITE PAIN (Arm is sore at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant was provided. Patient treatment information was no provided.
Pt received TD Intrathecally rather than PPD. Resulting in induration. No other RXN noted.
Cold like symptoms; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Cold like symptoms) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NASOPHARYNGITIS (Cold like symptoms). At the time of the report, NASOPHARYNGITIS (Cold like symptoms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment medications were reported.
Fever/erythema with streaking/lymphangitis. Tx: Zithromax po now then po qd x 4 days.
He received MMR/varicella vaccine about 2 wks ago. About 5 days after that he broke out in a rash on his face and body. The rash has started to improve over the lasted few days. He's doing well and did not have any other symptoms
on blood thinners; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: THROMBOSIS (medically significant), outcome "unknown", described as "on blood thinners". Therapeutic measures were taken as a result of thrombosis.  Clinical Course: Stop promoting this damn shot two of patient friends have ended up with heart problems and four are now on blood thinners for the rest of their lives.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202300014834 same reporter/drug, different patient/event;US-PFIZER INC-202300035009 same reporter/drug/event, different patient;US-PFIZER INC-202300035010 same reporter/drug/event, different patient;US-PFIZER INC-202300035011 same reporter/drug/event, different patient;
Pt has high risk co-morbidities/hx of reaction to first vax seen by Doctors -ok to vax  became shakey, monitor 40 mins, no shakiness when left
Site: Bruising at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Error: Shoulder Joint Injury (prolonged pain, tingling, etc.)-
Vaccine administered Friday. Pt. called on Monday to notify of reaction. Also stated reaction has been improving. Notes do not indicate if patient self treated with anything. Patient denied shortness of breath and hives.
Blistering rash experienced whit the first shoot of the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of RASH VESICULAR (Blistering rash experienced whit the first shoot of the vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (Was hospitalized due to Covid19 in December for a week before receiving the first shoot of the Moderna vaccine in march) in December 2020. Concurrent medical conditions included Blood pressure high, Fibromyalgia and Sleep loss.    In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH VESICULAR (Blistering rash experienced whit the first shoot of the vaccine). At the time of the report, RASH VESICULAR (Blistering rash experienced whit the first shoot of the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The concomitant medication were not reported. No treatment information was provided by the reporter.   This case was linked to MOD-2021-295770, MOD-2021-295024 (Patient Link).
Erythema and vesicles varicella #2, adv. ice pks and con. use Benadryl.
Dose 1 sept 13,2021.  Dose 2 oct 11,2021 Tinnitus. Keeps getting louder over time. I keep thinking it will get better but it?s getting worse
This spontaneous report as received from a physician refers to a 74 years old female patient who on 20-JAN-2008 was vaccinated with a dose of 0.65 ml ZOSTAVAX (route and lot number not reported). No other co-suspects were reported. No concomitant medications were reported. The physician reported that the patient called to the office and reported lower back pain. The doctor saw that the patient had a rash on her lower back and diagnosed it as shingles. The patient was treated with valacyclovir for adverse event. The patient sought medical attention. At the time of the report, the patient's outcome for adverse event was unknown. The relatedness for adverse events was unknown for ZOSTAVAX. Additional information has been requested.
3 doses given at 6, 10, and 14 weeks of age/states some of the doses had been administered; defective ROTATEQ/couple doses in their box were already opened/ dose given from opened pouch; This spontaneous report was received from a registered nurse refers to an infant of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported.  On an unknown dates, at the age of 6, 10 and 14 weeks old, the patient was vaccinated with 3 doses rotavirus vaccine, live, oral, pentavalent (ROTATEQ) orally, every 4 weeks (lot # S006159, expiration date was reported as 10-SEP-2020, but upon validation established as 10-NOV-2020, exact dose was not provided) for prophylaxis. A couple of doses (unspecified) in the current box were with the packaging already opened. None of the tubes were leaky. It appeared that the glue was not sticky enough and the packaging could be opened with minimal effort. It would stick back together if squeezed, but then would re-opened again. The box that rotavirus vaccine, live, oral, pentavalent (ROTATEQ) came in was intact but the pouches that individual doses come in were opened. The reporter stated that 2 or 3 doses out of 10 appeared to be opened. Some doses had been administered (unspecified).